| Natalie E Cook, MD | |
|
550 Munson Ave, Traverse City, MI 49686-3580 | |
| (231) 935-8686 | |
| (231) 935-8708 |
| Full Name | Natalie E Cook |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 550 Munson Ave, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164914214 | NPI | - | NPPES |
| 4301115615 | Other | MI | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301115615 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Paul Oliver Memorial Hospital | Frankfort, MI | Hospital |
| Kalkaska Memorial Health Center | Kalkaska, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thirlby Clinic Plc | 3274588116 | 10 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed for Schering Corporation's TEMODAR (Temozolomide) 5mg, 20mg, 100mg & 250mg capsules.
In a University of California, Irvine-led study, researchers found evidence that fasting affects circadian clocks in the liver and skeletal muscle, causing them to rewire their metabolism, which can ultimately lead to improved health and protection against aging-associated diseases.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine- scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.
› Verified 4 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed for Schering Corporation's TEMODAR (Temozolomide) 5mg, 20mg, 100mg & 250mg capsules.
In a University of California, Irvine-led study, researchers found evidence that fasting affects circadian clocks in the liver and skeletal muscle, causing them to rewire their metabolism, which can ultimately lead to improved health and protection against aging-associated diseases.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine- scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.
› Verified 4 days ago
| Entity Name | Thirlby Clinic Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780676684 PECOS PAC ID: 3274588116 Enrollment ID: O20050314000951 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed for Schering Corporation's TEMODAR (Temozolomide) 5mg, 20mg, 100mg & 250mg capsules.
In a University of California, Irvine-led study, researchers found evidence that fasting affects circadian clocks in the liver and skeletal muscle, causing them to rewire their metabolism, which can ultimately lead to improved health and protection against aging-associated diseases.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine- scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie E Cook, MD 550 Munson Ave, Traverse City, MI 49686-3580 Ph: (231) 935-8686 | Natalie E Cook, MD 550 Munson Ave, Traverse City, MI 49686-3580 Ph: (231) 935-8686 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed for Schering Corporation's TEMODAR (Temozolomide) 5mg, 20mg, 100mg & 250mg capsules.
In a University of California, Irvine-led study, researchers found evidence that fasting affects circadian clocks in the liver and skeletal muscle, causing them to rewire their metabolism, which can ultimately lead to improved health and protection against aging-associated diseases.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine- scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.
› Verified 4 days ago
Satya Pillay, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Medical Campus Dr, Traverse City, MI 49684 Phone: 231-935-8000 Fax: 231-935-8099 | |
Samantha K Windle, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Medical Campus Dr, Traverse City, MI 49684 Phone: 231-935-8000 Fax: 231-935-8099 | |
Dr. Donald James Aiken, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16544 Wrightwood Terrace Dr, Traverse City, MI 49686 Phone: 231-223-7465 | |
Kaitlyn Lee Kilpatrick, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Medical Campus Dr, Traverse City, MI 49684 Phone: 231-935-8000 Fax: 231-935-8099 | |
Ferris Alkazir, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-6600 Fax: 231-935-9290 | |
David J Wilcox, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 906 Business Park Dr, Traverse City, MI 49686 Phone: 800-968-6866 | |
Mark A Jackson, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1000 Pavilions Circle, Mark A Jackson Md Plc, Traverse City, MI 49684 Phone: 231-935-0913 Fax: 231-935-0984 |